Skip to main content
. 2021 Apr;12(Suppl 1):S5–S17. doi: 10.21037/jgo-20-129

Table 6. Cumulative incidence (CI) of GC progression events.

Cumulative incidence Control group, CI ± SE HIPEC group, CI ± SE Р value (Gray’s test)
Metachronous peritoneal metastases 72.8±6.4 24.0±5.5 <0.001
Liver metastases 3.6±2.6 19.3±5.1 0.015
Other metastases 4.0±2.9 9.6±3.8 0.137

GC, gastric cancer; SE, standard error.